Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Tesla heads into its October 21 Q3 results having recovered sharply from last week's lows, with short sellers still in retreat but options traders beginning to show the first signs of pre-earnings caution.
The stock closed at $380.68 on Tuesday, up 7.9% on the week and 7.5% over the past month. That recovery matters in context: the previous note, published September 30, caught Tesla sliding 6.9% to $352.84 with bears still covering. Those covers have continued. SI % FF now reads 2.03%, down from 2.66% on September 18 and roughly in line with the 2.07% reading flagged a week ago. The week-on-week change in shares short is a modest -1.8%, extending what has been a steady, orderly unwind rather than any panic exit. Borrow conditions remain completely loose. Cost to borrow ticked up 11.6% on the week to 0.39%, but that remains historically low for this name. Availability is effectively unconstrained. There is no friction in the lending market in either direction, no squeeze threat for bears, no signal of fresh conviction short building.
Options, by contrast, are beginning to move. The put/call ratio closed at 0.794, above its 20-day average of 0.783 and a full standard deviation above the mean on a z-score basis. That is not an alarm, but it is a directional shift. A week ago the ratio was essentially flat against its average; now it has nudged higher as the earnings date comes into view. The 52-week range on the PCR runs from 0.678 to 0.926, so the current reading sits in the middle of its own history, elevated relative to recent calm but far from the defensive extreme.
The Street's picture on Tesla remains genuinely divided, and recent analyst moves have not resolved that. JP Morgan's Rajat Gupta lowered his price target to $415 from $445 on September 28, maintaining a Neutral rating, the second consecutive cut from that desk after a prior trim from $475 in late July. Goldman Sachs reiterated Neutral at $360 in mid-September. Those two neutral stances bracket the current $380 price closely. On the bull side, StoneX holds a $475 target. The mean across the coverage universe sits at $397, implying modest upside from here. The factor picture adds texture to the split: the analyst recommendation divergence factor ranks in the 95th percentile, confirming that the Street is unusually spread in its views. Days-to-cover ranks in the 89th percentile, reflecting thin short interest relative to volume. EPS surprise, at the 27th percentile, flags a track record of missing estimates. The bear case rests heavily on Q2's $0.33 print against a $0.50 forecast, negative free cash flow of $1.1 billion, and a trailing PE now running near 186x. The bull case centres on energy storage growth, the Robotaxi and Cybercab pipeline, and forward revenue projections rising to $106.4 billion in 2026 and $134.2 billion in 2028.
The most differentiated data point heading into the print comes from German vehicle registrations, tracked by the Kraftfahrt-Bundesamt. This dataset has been measured to lead Tesla's quarterly revenue by 43 days, a strong fit over 18 quarters with a 100% directional hit rate. With two of three months of the Q3 window in, registrations stand at 3,401 vehicles, down 58.8% against the prior quarter. The year-on-year figure for August alone showed a 111% increase in German registrations, but the sequential quarter-on-quarter drop in the cumulative Q3 window is pronounced. This is where the data points for the quarter the October 21 print covers; it is not a forecast of the revenue line.
The earnings history adds a clear pattern worth tracking. The last quarterly result, on July 22, produced a one-day decline of 15.6% and a five-day move of -21.3%. That is the only recent datapoint available, but it is a large one. Options traders appear to be beginning to price that history back in, even if the PCR has only moved modestly so far. With 14 days to the print and the stock having recovered nearly $30 from last week's close, the question for the next two weeks is whether the options market's mild uptick in hedging demand continues to build, or whether the short cover trend and the rally hold the PCR near its current, calmer levels.
See the live data behind this article on ORTEX.
Open TSLA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
